Eris Lifesciences Limited (NSE:ERIS)

Eris Lifesciences Revenue

Eris Lifesciences had revenue of 7.22B INR in the quarter ending December 31, 2024, with 49.36% growth. This brings the company's revenue in the last twelve months to 27.24B, up 47.99% year-over-year. In the fiscal year ending March 31, 2024, Eris Lifesciences had annual revenue of 19.91B with 19.83% growth.

• Revenue (ttm): 27.24B
• Revenue Growth: +47.99%
• P/S Ratio: 6.39
• Revenue / Employee: 7.52M
• Employees: 3,620
• Market Cap: 174.13B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	19.91B	3.29B	19.83%
Mar 31, 2023	16.62B	3.36B	25.31%
Mar 31, 2022	13.26B	1.34B	11.20%
Mar 31, 2021	11.93B	1.34B	12.71%
Mar 31, 2020	10.58B	909.81M	9.41%